Skip to search.
 TSX Up 0.37% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
34.01 Down 0.56(1.62%) Apr 17, 4:00PM EDT
Add to Portfolio
Prev Close:34.57
Open:34.47
Bid:N/A
Ask:36.50 x 400
1y Target Est:54.44
Beta:1.58
Earnings Date:May 5 - May 9 (Est.)
Day's Range:33.54 - 35.41
52wk Range:18.27 - 62.66
Volume:1,000,099
Avg Vol (3m):1,950,570
Market Cap:3.99B
P/E (ttm):N/A
EPS (ttm):-0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 1.62%3.99B
ENZDown 0.46%182.67M
GILDUp 1.04%107.68B
SRPTUp 0.70%921.71M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.67
Quarterly EPS Est (Mar-14) :-0.21
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-2.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback